Clinical Trials Browser

Phase 1/2 × Head and Neck Neoplasms × Interleukin-12 × Clear all

NCT00004070 2017-04-20

Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer

Phase 1/2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms